The importance of a successful cell bank manufacture is at the forefront of new product development and the introduction of new regulations can mean having to pivot to ensure compliance. Getting it right the first time is important to you, and we can help you navigate the latest regulations.
In this webinar, you will learn when you need a Master Cell Bank (MCB), your Working Cell Bank(s), and other topics such as Cells at Limit (CAL) or End of Production (EOP) cell bank, how to make the most of your bank and how we can help you. We will cover how we have evolved our service offering to ensure that we meet Annex 1 compliance to ensure your cell banks are made to standard including animal origin-free expectations.
In this webinar, you will learn:
- Best practices for cell bank manufacturing
- How to get the most out of your cell bank
- The future of closed processing in line with Annex 1
Speakers
Angela Waugh
Merck
Global Scientific Lead, Manufacturing Value Stream
Angela has had various roles in her 22 years with Merck, from associate scientist to department manager, and she is currently the Global Scientific Lead for the Manufacturing Value Stream. In this role, she supports the global manufacturing teams, and clients and has a strong focus on regulatory compliance. Angela spent time building clinical trial experiences during which she developed a strong knowledge of GMP requirements. She holds a degree in applied biosciences from Glasgow Caledonian University.
Mee Chee Lee
Merck
Sales Development Manager, Upstream Services, Asia Pacific
Mee Chee Lee has more than 10 years of experience at Merck, where she is currently the upstream services sales development manager for Asia Pacific.
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
期间:1h
语言:English
场次 1:往期 July 18, 2023
如要继续阅读，请登录或创建帐户。
暂无帐户？